New treatment options in hormone-sensitive prostate cancer
نویسندگان
چکیده
منابع مشابه
Treatment options in hormone resistant prostate cancer.
Prostate cancer is the most frequently diagnosed cancer in humans. An estimated 189000 men will be diagnosed with prostate cancer in the USA in 2002, and an estimated 30200 will die as a result of the disease [1]. It is predominantly diagnosed in older men and is rarely diagnosed in men under the age of 40 in contrast with the observation that microscopic prostate cancer is present in 80–100% o...
متن کاملEvolving Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer.
Oligometastatic disease was postulated by Hellman and Weichselbaum in 1995 to be a disease state that may reflect a time point in the malignant process that may be amenable to local therapies to allow for patients to achieve a durable response or possible cure despite having advanced disease. Aggressive metastasis-directed therapy has been used in malignancies such as renal cell carcinoma, non-...
متن کاملNew treatment options in castration-resistant prostate cancer.
Most of the updates in the 2015 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer center on the systemic therapy front, with a host of newer agents in the mix. At the NCCN 20th Annual Conference, Dr. Andrew J. Armstrong discussed some of the key developments in metastatic castration-resistant and castration-sensitive prostate cancer, particularly the conflictin...
متن کاملThe possibility of hormone-mediated PSA derangement in prostate cancer treatment
Background: This study was designed to suggest the possibility of hormone-related derangement in salvage radiotherapy (SRT) after radical prostatectomy in terms of prostate-specific antigen (PSA) control. Materials and Methods: Among 160 consecutive prostate cancer patients who received radical prostatectomy, 34 with SRT between 2004 and 2012 were retrospectively reviewed. The numbers of patien...
متن کاملManagement of Hormone-Sensitive and Hormone-Refractory Metastatic Prostate Cancer.
BACKGROUND: Prostate cancer is a significant health problem in the United States and is the focus of increasing attention in our society. With the aging of the US population, it is likely that prostate cancer will continue to grow in importance. The options for systemic therapy of metastatic prostate cancer should be familiar to physicians, including nonspecialists, whose patients seek their ad...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Onkologie
سال: 2019
ISSN: 1802-4475,1803-5345
DOI: 10.36290/xon.2019.029